80 likes | 91 Views
Provides an overview of the current and future market for bio-based plastics in Europe, highlighting key drivers, barriers, and potential solutions. Based on extensive research and expert interviews.
E N D
Market Roadmap Bio-BasedPlastics Henna Jääskeläinen Pöyry Management Consulting 17 March, 2015
Market Roadmap • Focuses on the IB sector as a whole as well as on a selection of five IB business cases for Europe • Provides an overview of the current market in the EU with demand projections extending to 2030 • Provides information on the current and future value chains, highlighting key drivers and barriers impacting market development The current version is the final draft of the market roadmap and is based on literature study, 70 expert interviews and on the information collected through 8 regional and 5 business case specific workshops
Market Value of Industrial Biotechnology in the EU NOTE: In thisroadmap, demand for bio-basedplasticsrefer to allplasticsthatarebio-based, notonly to products producedthroughindustrialbiotechnology (IB)
Bio-BasedPlasticsin 2014 • Shale gas boom has halted planned projects • Volumes still very low compared to fossil-based plastics • Market drivenbypackagingapplications • Brand-owners committing to bio-based plastics Limited cost-competitiveness • Many new facilities are built outside Europe
Main Hurdles and Solutions (1/2) Valorisation of potential of IB in developing new functionalities Information campaigns to increase awareness of bio-based plastics by demonstrating their safety and environmental benefits with more harmonisedecolabels Selective bans on non-biodegradable plastics where biodegradable plastics have demonstrable environmental benefits Addedvalue compared to fossil plastics
Main Hurdlesand Solutions (2/2) Lack of common agenda for bioplastics development Common future agenda for both drop-in bio-based and biodegradable plastics by e.g. European Bioplastics Public procurement with periodic reporting
Valorisation of Potential of IB in Developing New Functionalities IMPACT? WHAT? WHEN? COST? WHO?
ContactDetails www.industrialbiotech-europe.eu Henna Jääskeläinen Pöyry Management Consulting henna.jaaskelainen@poyry.com